BRMEC11 Colloquium 2022

The eleventh Invest in ME Research Biomedical Research into ME Colloquium (BRMEC11)—"ME and Long Covid: Emerging insights in mechanisms and complexity of post-viral fatigue"—took place in London over two days: 18th–19th May 2022.

Developing deeper insights into ME mechanisms and Long Covid research connections.

ME, and more recently Long Covid, place a huge burden in healthcare yet the capacity of research has continually been restricted by limited funding.
With developments around research into Long Covid and with the similarities of some symptoms to those experienced by people with ME then this topic was also included as a central component of the agenda and a number of presentations concerning ME and long covid were given with a focus on the aetiology of the disease.
The knowledge and the road travelled by ME researchers and clinicians is an invaluable aid for understanding long Covid.
Understanding the viral and immunological mechanisms behind both of those conditions is the key to making progress.


Time Session Presenter(s)
12:45 Welcome - Open for joining
13:30 Opening of BRMEC11 Session Chair: Simon Carding

Quadram Institute, Norwich, UK

13:35 FS HISTORY of ME (and Long Covid) Friðbjörn Sigurðsson

Akureyri Hospital, Iceland

14:00

LONG COVID and ME

Session Chair: Markku Partinen

University of Helsinki, Finland

MP Similarites Between ME and Long covid Markku Partinen

University of Helsinki, Finland

BM Post-COVID and ME – same disease or not? Branislav Milovanović

University Clinical Center Bezanijska Kosa, Department of Cardiology, Neurocardiological laboratory, Belgrade, Serbia

To be announced To be announced
Open discussion Chaired discussion amongst participants
Break Break
15:45 AB

IMMUNITY

Session Chair: Amolak Bansal

Spire Hospitals, Surrey

SM NEF Ion channel function and long haul COVID and ME/CFS Sonya Marshall-Gradisnik and Natalie Eaton-Fitch
The National Centre for Neuroimmunology and Emerging Diseases (NCNED), Griffiths University, Australia
HO Genetics as a tool to understand chronic fatigue and Long COVID Hanna Ollila
FIMM-EMBL Group Leader, Institute for Molecular Medicine, University of Helsinki, Finland
To be confirmed To be confirmed
Open discussion

Chaired discussion amongst participants
Break Break
18:00 SmA

CNS and IMAGING

Session Chair: Simon McArthur

Queen Mary University London, UK

KTh LB Study of brain dysfunction in ME/CFS patients using magnetic resonance imaging Kiran Thapaliya and Associate Professor Leighton Barnden

National Centre for Neuroimmunology and Emerging Diseases (NCNED), Australia

To be announced To be announced
.
MVZ Functional Neuroimmune Imaging in ME/CFS and Long-COVID Michael VanElzakker

Massachusetts General Hospital/Tufts University, USA

PJ CBF changes in ME using ASL MRI Per Julin Department of Neurobiology, Karolinska Institutet, Sweden
.
Open discussion Chaired discussion amongst participants
20:00 FURTHER DISCUSSIONS and SUMMARY

Time Session Presenter(s)
12:45 Open for joining
13:30 Welcome Day 2 - BRMEC11
13:35 HO

HOST VIRUS INFECTION

Session Chair: Tom Wileman

Quadram Institute, Norwich, UK

JC title pending Jackie Cliff

Senior Lecturer in Immunology , Brunel University London, UK

BH title pending Bradlee Heckmann

Assistant Professor, University of South Florida, Neuroscience Institute, Byrd Alzheimer's Center, USA

LJ Prospective Research Using Pre-Illness Data Leonard Jason

DePaul University, Chicago,USA

To be announced To be announced
HP Human endogenous retroviruses (HERVs) can be activated by viral infections followed by long-term expression of pathogenic proteins: lessons from SARS-CoV-2 and post-COVID syndromes Hervé Perron

Chief Scientific Officer and Director of GeNeuro, Geneva, Switzerland

AN NIH Long Covid Study Avindra Nath

Clinical Director / Senior Investigator, Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke (NINDS), USA

Open discussion Chaired discussion amongst participants
Break Break
17:30 HO

CLINICAL and RESEARCH UPDATES

Session Chair: Jesper Mehlsen

Copenhagen, Denmark

HO Treatments for ME/CFS Session Chair: Jesper Mehlsen

Copenhagen, Denmark

HO BC007 - GPCR-autoantibodies in ME/CFS and Post-COVID19 patients Gerd Wallukat

Berlin, Germany

RD ME/CFS Causes, Treatments and Diagnostics Ron Davis

Stanford School of Medicine, California, USA

JB Time-resolved microsampling in ME patients to follow acute effects of exposure and interventions Jonas Bergquist

Uppsala University, Sweden

Open discussion Chaired discussion amongst participants
19:35 FURTHER DISCUSSIONS and SUMMARY DAY 2


Share this page:

Last updated: December 2025